Investor List:

Top Digital Health Series B Investors in Boston / New England (160)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Digital Health investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Andrew Hedin, Partner at Bessemer Venture Partners
Andrew Hedin
Sweet spot: $25.0M
Range: $1M - $250.0M
Investors in Redwood City (CA), Investors in Boston (MA)
Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Digital Health (Seed), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Internet (Series A), Investors in Digital Health (Series B), Investors in Consumer Internet (Seed), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists), Investors in Consumer Internet (Series B), Investors in Health IT (Seed), Investors in Consumer Internet (Series B), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Eyal Gura, Investor at Webtalk Ltd
Eyal Gura
Webtalk Ltd·Investor
Sweet spot: $200K
Range: $100K - $500K
Investors in California, Investors in Boston (MA), Investors in Israel
Investors in Consumer Health (Series B), Investors in AI (Seed), Investors in AI (Series B), Investors in Advertising (Series B), Investors in Advertising (Series B), Investors in Digital Health (Series A), Investors in AgTech (Series B), Investors in AI (Pre-seed), Investors in Digital Health (Series B), Investors in AgTech (Pre-seed), Investors in AI (Pre-seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in Advertising (Seed), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Payments (Pre-seed), Investors in Advertising (Pre-seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Advertising (Series A), Investors in Advertising (Series A), Investors in Developer Tools (Series B), Investors in Digital Health (Seed), Investors in DeepTech (Pre-seed), Investors in Consumer Health (Seed), Investors in AI (Seed), Investors in AgTech (Series B), Investors in DeepTech (Seed), Investors in Advertising (Pre-seed), Investors in Digital Health (Series A), Investors in AI (Series B), Investors in AgTech (Series A), Investors in AI (Series A), Investors in Advertising (Seed), Investors in Payments (Series B), Investors in Developer Tools (Series A), Investors in DeepTech (Seed), Investors in AI (Series A), Investors in AgTech (Pre-seed), Investors in Developer Tools (Pre-seed), Investors in Payments (Series B), Investors in Developer Tools (Series B), Investors in Digital Health (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Developer Tools (Seed), Investors in AgTech (Series A), Investors in Payments (Pre-seed), Investors in AgTech (Seed), Investors in SaaS (Series B), Investors in Payments (Seed), Investors in Enterprise (Series B), Investors in Payments (Series A), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Seed), Investors in Payments (Seed), Investors in AgTech (Seed), Investors in Payments (Series A), Investors in Consumer Health (Series B), Investors in Developer Tools (Pre-seed), Investors in SaaS (Pre-seed), Investors in Developer Tools (Seed), Investors in SaaS (Series B), Investors in Developer Tools (Series A), Investors in Enterprise (Pre-seed), Investors in SaaS (Series A), Investors in DeepTech (Series B), Investors in Consumer Health (Series A), Investors in Enterprise (Series B), Investors in Consumer Health (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Pre-seed), Investors in Advertising (Series B), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in SaaS (Pre-seed), Investors in Digital Health (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Advertising (Pre-seed), Investors in AgTech (Series B), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in AgTech (Pre-seed), Investors in DeepTech (Series A), Investors in SaaS (Seed), Investors in Advertising (Series A), Investors in Payments (Pre-seed), Investors in Payments (Series B), Investors in Enterprise (Seed), Investors in AgTech (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in DeepTech (Seed), Investors in Advertising (Seed), Investors in Consumer Health (Pre-seed), Investors in AI (Pre-seed), Investors in Developer Tools (Series B), Investors in Payments (Series A), Investors in AgTech (Seed), Investors in Developer Tools (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Payments (Seed), Investors in AI (Series B), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in AI (Seed), Investors in Developer Tools (Series A), Investors in Consumer Health (Seed), Investors in Developer Tools (Seed), Investors in SaaS (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in SaaS (Series A), Investors in SaaS (Seed), Investors in Enterprise (Series A), Investors in Israel (Other Lists), Investors in Enterprise (Seed), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Photo of Gary Swart, General Partner at Polaris Partners
Gary Swart
Polaris Partners·General Partner
Sweet spot: $500K
Range: $300K - $2.0M
Investors in Atherton, Investors in Boston (MA), Investors in San Francisco (CA), Investors in New York (NY)
Investors in Human Capital/HRTech (Series B), Investors in Human Capital/HRTech (Seed), Investors in Human Capital/HRTech (Series A), Investors in Human Capital/HRTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Human Capital/HRTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Human Capital/HRTech (Seed), Investors in Sales & CRM (Series B), Investors in Sales & CRM (Series B), Investors in Human Capital/HRTech (Series B), Investors in Sales & CRM (Seed), Investors in Health IT (Series A), Investors in Human Capital/HRTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Sales & CRM (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Marketplaces (Series B), Investors in Health & Hospital Services (Seed), Investors in Sales & CRM (Series A), Investors in Human Capital/HRTech (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in Sales & CRM (Seed), Investors in Human Capital/HRTech (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Enterprise (Series B), Investors in Digital Health (Seed), Investors in Marketplaces (Series A), Investors in Human Capital/HRTech (Series A), Investors in Human Capital/HRTech (Seed), Investors in AI (Series A), Investors in Sales & CRM (Series B), Investors in Marketplaces (Seed), Investors in Health IT (Series A), Investors in Sales & CRM (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series A), Investors in AI (Seed), Investors in Future of Work (Series B), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Marketplaces (Series B), Investors in Enterprise (Series A), Investors in AI (Series B), Investors in Enterprise (Seed), Investors in Sales & CRM (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Sales & CRM (Seed), Investors in Sales & CRM (Series A), Investors in Digital Health (Seed), Investors in Enterprise (Series B), Investors in Sales & CRM (Seed), Investors in Future of Work (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Marketplaces (Series A), Investors in Health IT (Series B), Investors in Marketplaces (Seed), Investors in Future of Work (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Seed), Investors in Enterprise (Series A), Investors in Health IT (Series B), Investors in Marketplaces (Series B), Investors in Health & Hospital Services (Series A), Investors in Enterprise (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Marketplaces (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in Health IT (Seed), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in Marketplaces (Seed), Investors in Marketplaces (Series A), Investors in Enterprise (Series B), Investors in AI (Series A), Investors in AI (Seed), Investors in Marketplaces (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Peter Spring, Managing Director at Bain Capital
Peter Spring
Bain Capital·Managing Director
Sweet spot: $25.0M
Range: $1M - $100.0M
Investors in Boston (MA)
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Therapeutics (Series A), Investors in Diagnostics (Seed), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Seed), Investors in Manufacturing (Series B), Investors in Diagnostics (Seed), Investors in Manufacturing (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Manufacturing (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in Manufacturing (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Seed), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Manufacturing (Series B), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in Manufacturing (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Sofia Guerra, Vice President at Bessemer Venture Partners
Sofia Guerra
Sweet spot: $25.0M
Range: $50K - $100.0M
Investors in Cambridge (MA)
Photo of Saron Tesfalul, Principal at Bain Capital
Saron Tesfalul
Bain Capital·Principal
Sweet spot: $25.0M
Range: $1M - $100.0M
Investors in Boston (MA)
Photo of Paul Moskowitz, Principal at Bain Capital
Paul Moskowitz
Bain Capital·Principal
Sweet spot: $25.0M
Range: $1M - $100.0M
Investors in Boston (MA)